Approval · Notice of Compliance 4207 · 1996
EMINASE: Notice of Compliance 4207
Issued August 28, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4207
- Date
- August 28, 1996
- Company
- Roberts Pharmaceutical Canada Inc.Oakville, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Fibrinolytic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMINASE | 02229390 | Cancelled Post Market |
Medicinal ingredients
- ANISTREPLASE 30 UNIT per VIAL